Table 1.
Evaluation of CE and piceatannol’s activity against various viruses.
| Cells | Viruses | CE (µg/mL) | Piceatannol(µM) |
|---|---|---|---|
| HEL | Herpes simplex virus-1 (KOS) | 46.7 ± 2.9 | 47.5 ± 3.5 |
| HEL | Herpes simplex virus-2 (G) | 39.5 ± 5.5 | 45.0 ± 1.8 |
| HEL | Herpes simplex virus-1 TK KOS ACV | 45.0 ± 2.6 | 45.4 ± 4.0 |
| U87 | Vesicular stomatitis virus | >100 | 79.2± 17 |
| MDCK | Influenza A/H1N1 A/Ned/378/05 | >100 | >100 |
| MDCK | Influenza A/H3N2 A/HK/7/87 | >100 | >100 |
| MDCK | Influenza B B/Ned/537/05 | >100 | >100 |
| Huh 7-D | Hepatitis C virus (Jc1) | >100 | >100 |
| HeLa | Coxsackie virus B4 | >100 | >100 |
| vero | Coxsackie virus B4 | >100 | >100 |
| HeLa | Respiratory syncytial virus | >100 | >100 |
| vero | Para-influenza-3 virus | >100 | >100 |
| vero | Reovirus-1 | >100 | >100 |
| vero | sindbisvirus | >100 | >100 |
| vero | Punta toro virus | >100 | >100 |
| vero | Yellow fever virus | >100 | >100 |
| CRFK | Feline corona virus (FIPV) | >100 | >100 |
| CRFK | Feline herpes virus | >100 | >100 |
| HEL | Human corona virus | >100 | >100 |
IC50 (inhibitory concentration of viral replication by 50%), CE, crude extract of C. abbreviata.